Search for Clinical Trial Results

Sponsored By

Chronic Neutrophilic Leukemia - 11 Studies Found

Status Study
Recruiting Study Name: Ruxolitinib Phosphate in Treating Patients With Chronic Neutrophilic Leukemia or Atypical Chronic Myeloid Leukemia
Condition:
  • Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative
  • Chronic Neutrophi
    Date: 2014-03-18
    Interventions:
    • Other: Laboratory Biomarker Analysis

Withdrawn Study Name: Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant
Condition:
  • Accelerated Phase Chronic Myelogenous Leukemia
  • Adult Acute Lymphoblastic Leukemia in Remissi
    Date: 2012-03-16
    Interventions:
    • Procedure: management of therapy complications

Completed Study Name: Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia
Condition:
  • Adult Acute Lymphoblastic Leukemia
  • Adult Acute Myeloid Leukemia
  • Adult Acute Lymphoblastic Leukemia in Remission
  • Adult Acute Myeloid Leukemia in Remission Date: 2011-06-27
    Interventions:
    • Drug: Fludarabine Given IV
Completed Study Name: Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant
Condition:
  • Childhood Acute Lymphoblastic Leukemia in Remission
  • Childhood Acute Myeloid Leukemia in Remi
    Date: 2011-02-25
    Interventions:
    • Drug: supersaturated calcium phosphate rinse

Completed Study Name: Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer
Condition:
  • Accelerated Phase Chronic Myelogenous Leukemia
  • Adult Acute Lymphoblastic Leukemia in Remissi
    Date: 2010-11-02
    Interventions:
    • Biological: palifermin Given I
Terminated Study Name: Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload
Condition:
  • Iron Overload
  • Accelerated Phase Chronic Myelogenous Leukemia
  • Accelerated Phase Chronic Myelogenous Leukemia
  • Adult Acute Lymphoblastic Leukemia in Remissi
    Date: 2008-11-26
    Interventions:
    • Other: internet-based intervention

Completed Study Name: Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant
Condition:
  • Accelerated Phase Chronic Myelogenous Leukemia
  • Adult Acute Lymphoblastic Leukemia in Remissi
    Date: 2008-11-20
    Interventions:
    • Drug: ondansetron Given IV
Withdrawn Study Name: Aprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With Cancer
Condition:
  • Myeloproliferative Disorders
  • Leukemia
  • Lymphoma
  • Date: 2007-07-10
    Interventions:
    • Drug: aprepitant 125 mg orally
Next >>>